Why Do These Anti-Infammatory Drugs have Less Side Effects?

Facebook
Google+
http://www.b-tv.com/nuvo-pharmaceuticals-ceo-clip
Twitter
LinkedIn

President & CEO, John London, Nuvo Pharmaceuticals (NRI:TSX), explains how their company’s topical anti-inflammatory drugs are different from oral drugs.

I’m John London. I am the President and CEO of Nuvo Pharmaceuticals Inc.  We’ve been successful in getting a number of products approved by the FDA that we’re selling and generating revenue.  Our lead products are Pennsaid and Pennsaid 2% so both of those products are topical nsaids or non-steroidal anti-inflammatory drugs.  The main problem that we are solving is the side effect issues of oral nsaids which are significant in the gastro-intestinal bleeding, the cardiovascular risk issues.

So the opportunity to have a topical that’s non systemic that really doesn’t get into the blood stream in any significant way but that works for arthritis, that’s a significant advancement.  Original Pennsaid was approved several years ago and it’s sold in Canada, Europe, Greece, Italy the UK.

Pennsaid 2% which is the follow on product which is significantly improved in particular because it’s twice a day dosing as supposed to four times a day for original Pennsaid. It’s currently approved only in the United States, and our strategy is to roll that product out around the world throughout licensing transactions with partners that have a commercial presence in each of the geographic territories.

We have sales, we have profits and I think that as people see growing revenue and profitability that they will be fascinated by Nuvo Pharma as an investment.

 

Request Investor Kit

Name*

Email*

*required.

Related News

BTVLogo1
Shot on location and broadcast on national TV, BTV takes INVESTORS directly to companies! Now 18 years strong and Canada’s longest running business show, BTV-Business Television, a weekly investor program, features emerging companies and top analysts across the US and Canada. With Host, Taylor Thoen, BTV goes on location, interviewing key executives and showcasing their business to give investors insight and help them grow their portfolio. BTV is broadcast internationally to millions on TV via BNN, US Biz Network and Air Canada and top financial sites including: Bloomberg, Yahoo Finance, TMX Money, BNN.ca, Reuters, Globe Investor, OTC Markets, The National Post, MarketWatch, Stockhouse.com, etc. For upcoming episodes and how to have your company featured contact trina@b-tv.com.

Watch BTV
ceo-clips-footer-logo
Meet the CEO before you invest! CEO Clips, Canada’s largest library of publicly traded company videos. Did you know management is one of the top three reasons why investors buy a stock? CEO Clips are 90 second video profiles designed to help investors make an educated buying decision. CEO Clips are broadcast on national TV and distributed on top financial sites including: Bloomberg, Yahoo Finance, TMX Money, BNN.ca, Reuters, Globe Investor, OTC Markets, The National Post, MarketWatch, Stockhouse.com, etc. According to Forbes, 60% of people prefer watching video over reading text. We’ve featured over 2000 companies; what are you waiting for? To produced your CEO Clip, contact trina@b-tv.com.

Watch CEO Clips
Broadcast On

© 2017 Business Television All Rights Reserved